DUBLIN--(BUSINESS WIRE)--The "Innovations in Liquid Biopsy Techniques for Cancer Management" report has been added to Research and Markets' offering.
This research service encompasses a comprehensive analysis of minimally-invasive and non-invasive biopsy platforms that enable enhanced tumor profiling, treatment monitoring and precision oncology applications. This service primarily focuses on the use of circulating tumor DNA (ctDNA) circulating tumor cells (CTCs) and extracellular vesicles (EVs), derived from bio-fluids such as blood and urine, for molecular analysis across research and healthcare settings.
This study also evaluates the technology, clinical, patent, and application landscapes prevalent across liquid biopsy settings, while providing valuable insights across its global technological impact and future perspectives.
Key Topics Covered:
1.0 Executive Summary
2.0 Technology Snapshot and Overview
3.0 Technologies Analyzing ctDNA
4.0 Technologies Enabling CTC Detection
5.0 Technologies for Assessment of Extracellular Vesicles
6.0 Impact Analysis and Future Perspectives
7.0 Growth Opportunities and Companies to Action
For more information about this report visit https://www.researchandmarkets.com/research/kjk8cv/innovations_in